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Abstract
A recent study documented a large increase in prescriptions of stimulants and antidepressants among
preschoolers, and has prompted public and professional concern about the effects of mood-altering
drugs on young children. In response, the White House announced a broad initiative on children’s mental
health, including more government money for research, new labels on drugs for pediatric use, educational
materials for parents, and a fall White House conference. To place these events in their larger context, this
Issue Brief summarizes the findings of the Children’s Mental Health Alliance Project, which conducted a
multidisciplinary consensus conference in November 1998 followed by a year-long dialogue with
clinicians, researchers, and families.
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The shifting landscape
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Editor’s Note: A recent study documented a large increase in prescriptions of stimulants
and antidepressants among preschoolers, and has prompted public and professional
concern about the effects of mood-altering drugs on young children. In response, the
White House announced a broad initiative on children’s mental health, including more
government money for research, new labels on drugs for pediatric use, educational
materials for parents, and a fall White House conference. To place these events in their
larger context, this Issue Brief summarizes the findings of the Children’s Mental Health
Alliance Project, which conducted a multidisciplinary consensus conference in November
1998 followed by a year-long dialogue with clinicians, researchers, and families.

The landscape for children’s mental health services has changed dramatically in the past
decade, due to the confluence of several factors.
• The “decade of the brain” has witnessed the increased use of psychotropic
medications, and further development of biological psychiatry. Advances in
psychopharmacology have led to many breakthrough treatments, particularly in mood
disorders among adults. Psychotropic medications are now being used in children as
well, although extrapolation of safety and efficacy data from adults is not always valid.
• The emergence of managed care has shifted children’s mental health care from
specialists to primary care providers. Community surveys indicate that in some areas,
two-thirds of children with psychiatric disorders do not receive specialist care.
• Epidemiological research has documented the under-recognition of mental health
problems, and resulting unmet needs, of children in primary care. Roughly one in
five children attending pediatric practices has significant mental health problems. It is
estimated that 60% of them do not receive the services that they need.

Psychotropic drug use in
children grows dramatically

Despite a lack of data on the outcomes of treatment with many psychotropic medicines
among children, their use in children is rising. The most common psychotropic
medications prescribed are stimulants to treat attention deficit hyperactivity disorder
(ADHD), and antidepressants.
• In the last 15 years, the 5-through-14-year-old age group has experienced a great
increase in stimulant treatment for ADHD, and the 15-through-19-year-old age
group has had sizable increases in the use of antidepressants.
• Public concern has focused on the possibility that psychotropic drugs are being
overutilized in children. However, the level of psychotropic drug use may reflect the

actual prevalence of childhood mental disorders. According to the 1999 Surgeon
General’s Report on Mental Health, about 6 to 9 million children and adolescents
have “serious emotional disturbances”, accounting for 9% to 13% of all children.
Alternately, the increased utilization could reflect a societal shift toward including
learning and developmental problems within the mental health sphere.
• A recent study in the Journal of the American Medical Association found that the
number of preschoolers taking stimulants more than doubled between 1991 and
1995, and the number of children on antidepressants increased 200%. Overall, the
results suggest that 1% to 1.5% of children ages 2 to 4 years old may be taking
stimulants, antidepressants, or antipsychotic medications.
• Among children, 75% to 80% of psychotropic medication is prescribed off-label,
meaning that its use is not officially approved by the Food and Drug Administration
for this age group. For example, Ritalin, a stimulant used to treat ADHD, has not
been tested or approved for use in children below age six.
• Practice patterns have outpaced the research on the effectiveness of different treatment
options. There is good evidence that sustained treatment with medication provides
continued benefit for children over six with ADHD; there is far less evidence
supporting the use of medication to treat children with anxiety or mood disorders.

Managed care affects who
delivers mental health
services to children

With the proliferation of managed care organizations, primary care providers often
function as gatekeepers—sometimes with disincentives to refer to mental health
specialists. However, the overall impact of managed care on access to and quality of
children’s mental health services is not clear.
• Research on the impact of managed care is hampered by the rapid evolution of
managed care, the turnover of managed care organizations, and the lack of a
consistent database that would allow tracking of outcomes.
• Mental health care carve-outs are rapidly expanding within managed care. In a typical
carve-out program, an independent company contracts with the managed care plan to
provide mental health services, usually on a capitated basis. Advantages of this
approach are that providers can focus on specific conditions and offer competitive
capitated rates. The disadvantages of carve-outs are that they allow less integration
with primary care, and exacerbate the separation between physical and mental health.
Carve-outs challenge the fundamental collaborative model of care for children and
families.
• Emerging studies on mental health carve-outs (in adults) document 30% to 40% cost
reductions, although apparent reductions might instead represent cost shifting to
other entities (such as public agencies, primary care providers or schools). Carve-outs
generally save money by reducing hospitalizations, shifting inpatient to outpatient
care, and replacing psychiatrists with masters-level therapists. However, the impact
on quality of care is unknown.

Primary care providers
need additional resources
to identify and address
children’s mental health
needs

The current “scorecard” on mental health screening of children in primary care is not
optimistic. The constraints of primary care practice (13 minutes allotted per visit on
average), and the limited availability of mental health specialists, make it difficult for
pediatricians and family practitioners to implement systematic screening procedures or
diagnostic assessments.
• Valid screening tools exist (for example, the Pediatric Symptom Checklist), but
primary care providers often lack the information or resources necessary to act on the

results. Studies show that even when psychosocial issues are elicited as part of wellchild visits, primary care providers respond with information, reassurance, guidance
or referral less than half the time.
• Many primary care providers express concern about making the right diagnosis,
choosing the right treatment modality, and picking the right medication when facing
mental health problems in children. To address identified mental health problems,
primary care providers need readily available information regarding next steps,
including accessible mental health referral sources and direct consultation with
specialists.
• Outcomes data are needed to develop an evidence-based approach to what works in
children’s mental health service delivery. Such studies would help redefine what
constitutes “best practices” in the primary care/specialist relationship as it pertains to
children’s mental health, rather than continue to have payers and mental health
professional shortages determine the frequency, level, modality and provider of mental
health services.

A system of care model holds
promise for children’s
mental health

Many experts recognize the need for a system of care that integrates mental health
services with other health and social services. A systems approach can be seen as a
“carve-in” to meet the needs of children and families.
• “System of Care” studies show that integrated systems provide better access to
treatment, greater continuity of care, and higher client satisfaction, but at higher cost
and with questionable improvements in outcomes. Evaluating the effectiveness of
such systems poses a complex and vexing challenge because it involves identifying
hard-to-measure outcomes from multiple domains.
• School-based centers provide a unique opportunity to provide access to mental health
care to children, but programs have been implemented in a piecemeal fashion.
A comprehensive approach is needed to integrate these programs, and place them
within a continuum of interventions addressing behavioral, learning, and emotional
problems that affect development and learning.

Setting a research agenda

An evidence-based approach to children’s mental health problems is needed and must
address the complexity of working with several levels of primary care providers and
specialists. Practice guidelines should be developed to guide the referral process and
reduce variations in care.
• The limited evidence about the efficacy of psychotropic drugs for children is
hindering development of an evidence-based approach to care. Several research
initiatives are underway, but other studies are needed, especially addressing the
efficacy of combinations of drugs and combinations of drugs and psychotherapy.
• There is limited evidence about the effectiveness of primary versus specialty care.
Studying “usual care” in real-life settings is essential in translating research into
practice. Measures of function, outcome, quality, readiness for change, parental and
family function, and systems coordination need to be developed to fully capture the
complexity of the factors that affect children’s mental health.
• Research on the cost-effectiveness of children’s mental health programs in primary
care is underdeveloped. Studies are needed to analyze costs in terms of long-term
outcomes, impact on other systems (juvenile justice, schools, etc.) and effects on other
populations. Long-term studies would clarify the extent to which early mental health
interventions prevent or reduce adult mental health problems and disability.

POLICY IMPLICATIONS

The Children’s Mental Health Alliance Project developed recommendations for
policymakers to overcome the increasing fragmentation of the health care system and to
address the burden of illness arising from unrecognized or untreated mental health
problems in children.
• Universal coverage and comprehensive mental health benefits are a necessary, though
not sufficient, condition for receiving appropriate treatment. Mental health services
for children and adolescents should be integrated into or closely coordinated with
overall health care of children and families.
• Managed care organizations, especially those serving Medicaid populations, should be
required to demonstrate coordination and a system of care. Funding streams for
children’s mental health issues should be united and tied to a consolidated, rather
than categorical, system of care.
• Primary care providers need increased training in the diagnosis and management of
common mental health problems and appropriate screening tools that fit into the
demands of busy office practices. To integrate mental health services into primary
care, guidelines should be developed that clarify the roles of primary and specialty
care providers, and guide decisions on when to refer.
• A uniform approach should be taken to track quality indicators in children’s mental
health care. For example, potential consumers and managers should have access to
information regarding how a health plan identifies children with mental health needs,
the average number of visits for a mental health problem, and the percentage of
children treated pharmacologically for a mental health concern.
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